141 related articles for article (PubMed ID: 38305509)
1. RACK1 promotes the occurrence and progression of cervical carcinoma.
Yang D; Lu X; Zhang X; Zhang X; Zhu L; Liu Q
J Clin Lab Anal; 2024 Feb; 38(4):e25012. PubMed ID: 38305509
[TBL] [Abstract][Full Text] [Related]
2. The receptor for activated protein kinase C promotes cell growth, invasion and migration in cervical cancer.
Liao S; Xiao S; Chen H; Zhang M; Chen Z; Long Y; Gao L; He J; Ge Y; Yi W; Wu M; Li G; Zhou Y
Int J Oncol; 2017 Nov; 51(5):1497-1507. PubMed ID: 29048616
[TBL] [Abstract][Full Text] [Related]
3. RACK1 promotes the invasive activities and lymph node metastasis of cervical cancer via galectin-1.
Wu H; Song S; Yan A; Guo X; Chang L; Xu L; Hu L; Kuang M; Liu B; He D; Zhao R; Wang L; Wu X; Gu J; Ruan Y
Cancer Lett; 2020 Jan; 469():287-300. PubMed ID: 31705928
[TBL] [Abstract][Full Text] [Related]
4. O-GlcNAcylation of RACK1 promotes hepatocellular carcinogenesis.
Duan F; Wu H; Jia D; Wu W; Ren S; Wang L; Song S; Guo X; Liu F; Ruan Y; Gu J
J Hepatol; 2018 Jun; 68(6):1191-1202. PubMed ID: 29454068
[TBL] [Abstract][Full Text] [Related]
5. Receptor for activated C kinase 1 promotes cervical cancer lymph node metastasis via the glycolysis‑dependent AKT/mTOR signaling.
Xu L; Li J; Tursun M; Hai Y; Tursun H; Mamtimin B; Hasim A
Int J Oncol; 2022 Jul; 61(1):. PubMed ID: 35616137
[TBL] [Abstract][Full Text] [Related]
6. PHB2 promotes tumorigenesis
Wu B; Chang N; Xi H; Xiong J; Zhou Y; Wu Y; Wu S; Wang N; Yi H; Song Y; Chen L; Zhang J
Theranostics; 2021; 11(7):3150-3166. PubMed ID: 33537079
[No Abstract] [Full Text] [Related]
7. The important role of the receptor for activated C kinase 1 (RACK1) in nasopharyngeal carcinoma progression.
Peng H; Gong PG; Li JB; Cai LM; Yang L; Liu YY; Yao KT; Li X
J Transl Med; 2016 May; 14(1):131. PubMed ID: 27170279
[TBL] [Abstract][Full Text] [Related]
8. CPNE1 promotes non-small cell lung cancer progression by interacting with RACK1 via the MET signaling pathway.
Wang A; Yang W; Li Y; Zhang Y; Zhou J; Zhang R; Zhang W; Zhu J; Zeng Y; Liu Z; Huang JA
Cell Commun Signal; 2022 Jan; 20(1):16. PubMed ID: 35101055
[TBL] [Abstract][Full Text] [Related]
9. RACK1 overexpression associates with pancreatic ductal adenocarcinoma growth and poor prognosis.
Li X; Xiao Y; Fan S; Xiao M; Wang X; Chen X; Li C; Zong G; Zhou G; Wan C
Exp Mol Pathol; 2016 Oct; 101(2):176-186. PubMed ID: 27498047
[TBL] [Abstract][Full Text] [Related]
10. Loss of RACK1 promotes glutamine addiction via activating AKT/mTOR/ASCT2 axis to facilitate tumor growth in gastric cancer.
Chen M; Wang G; Xu Z; Sun J; Liu B; Chang L; Gu J; Ruan Y; Gao X; Song S
Cell Oncol (Dordr); 2024 Feb; 47(1):113-128. PubMed ID: 37578594
[TBL] [Abstract][Full Text] [Related]
11. Receptor for activated C kinase 1 (RACK1) promotes the progression of OSCC via the AKT/mTOR pathway.
Zhang X; Liu N; Ma D; Liu L; Jiang L; Zhou Y; Zeng X; Li J; Chen Q
Int J Oncol; 2016 Aug; 49(2):539-48. PubMed ID: 27279145
[TBL] [Abstract][Full Text] [Related]
12. RACK1 promotes lung cancer cell growth via an MCM7/RACK1/ Akt signaling complex.
Fei L; Ma Y; Zhang M; Liu X; Luo Y; Wang C; Zhang H; Zhang W; Han Y
Oncotarget; 2017 Jun; 8(25):40501-40513. PubMed ID: 28465488
[TBL] [Abstract][Full Text] [Related]
13. RACK1 predicts poor prognosis and regulates progression of esophageal squamous cell carcinoma through its epithelial-mesenchymal transition.
Wang N; Liu F; Cao F; Jia Y; Wang J; Ma W; Tan B; Wang K; Song Q; Cheng Y
Cancer Biol Ther; 2015; 16(4):528-40. PubMed ID: 25719728
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of tumor suppressor RACK1 by Helicobacter pylori infection promotes gastric carcinogenesis through the integrin β-1/NF-κB signaling pathway.
Hu Y; Liu JP; Li XY; Cai Y; He C; Li NS; Xie C; Xiong ZJ; Ge ZM; Lu NH; Zhu Y
Cancer Lett; 2019 May; 450():144-154. PubMed ID: 30849478
[TBL] [Abstract][Full Text] [Related]
15. RACK1 promoted the growth and migration of the cancer cells in the progression of esophageal squamous cell carcinoma.
Hu F; Tao Z; Wang M; Li G; Zhang Y; Zhong H; Xiao H; Xie X; Ju M
Tumour Biol; 2013 Dec; 34(6):3893-9. PubMed ID: 23893384
[TBL] [Abstract][Full Text] [Related]
16. RACK1 promotes breast carcinoma proliferation and invasion/metastasis in vitro and in vivo.
Cao XX; Xu JD; Xu JW; Liu XL; Cheng YY; Wang WJ; Li QQ; Chen Q; Xu ZD; Liu XP
Breast Cancer Res Treat; 2010 Sep; 123(2):375-86. PubMed ID: 19946739
[TBL] [Abstract][Full Text] [Related]
17. PER1 suppresses glycolysis and cell proliferation in oral squamous cell carcinoma via the PER1/RACK1/PI3K signaling complex.
Gong X; Tang H; Yang K
Cell Death Dis; 2021 Mar; 12(3):276. PubMed ID: 33723221
[TBL] [Abstract][Full Text] [Related]
18. RACK1 promotes tumorigenicity of colon cancer by inducing cell autophagy.
Xiao T; Zhu W; Huang W; Lu SS; Li XH; Xiao ZQ; Yi H
Cell Death Dis; 2018 Nov; 9(12):1148. PubMed ID: 30451832
[TBL] [Abstract][Full Text] [Related]
19. OTUB1's role in promoting OSCC development by stabilizing RACK1 involves cell proliferation, migration, invasion, and tumor-associated macrophage M1 polarization.
Li Y; Li R; Qin H; He H; Li S
Cell Signal; 2023 Oct; 110():110835. PubMed ID: 37532135
[TBL] [Abstract][Full Text] [Related]
20. Ribosomal RACK1 promotes chemoresistance and growth in human hepatocellular carcinoma.
Ruan Y; Sun L; Hao Y; Wang L; Xu J; Zhang W; Xie J; Guo L; Zhou L; Yun X; Zhu H; Shen A; Gu J
J Clin Invest; 2012 Jul; 122(7):2554-66. PubMed ID: 22653060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]